 Ampio Pharmaceuticals Inc AMEX:AMPE shares are trading significantly higher Thursday following bullish analyst coverage. Alliance Global Partners analyst James Molloy initiated coverage on Ampio Pharmaceuticals with a Buy rating and announced a 4.50 price target, which is well. 